Neuropincis A Clinical Stage Biotechnology Company Developing New Medicines For Central Nervous System Disordersincluding Strokesevere Painsubarachnoid Hemorrhagesah And Treatment Resistant Depressionits Technology Targets The Glun2B Subunit Of Neuronal Nmda Receptors And Its Potential Therapeutic Benefitmulti Year Funding From The Nih Supports Neurop S Research And Development Programs For Np10679Its Drug Candidate For The Prevention Of Ischemic Damage During A Stroke Or Subarachnoid Hemorrhagesahand Severe Painfor More Informationplease Visit Www Neuropinc Com
No conferences found for this company.
| Company Name | Neurop Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
